Abstract:Targeted drug delivery using biological ligands can improve the precision of cancer therapy. However, this active targeting strategy is limited in tumor targeting and penetration abilities due to the paucity and heterogeneous distribution of targeted receptors in tumor cells, thus compromising the treatment outcomes. In this study, we developed an alternative active targeting strategy for enhanced tumor targeting and penetration through synthetic nanoparticle-mediated metabolic tumor ligand labeling for intercellular delivery of bioorthogonal chemical receptors combined with in vivo bioorthogonal click chemistry. Briefly, artificial azide-containing ligands were first labeled on perivascular tumor cells by nanoscale metabolic precursors (Az-NPs) via the enhanced permeability and retention (EPR) effect and metabolic engineering of the tumor cells. Through transport by extracellular vesicles (EVs) secreted by perivascular tumor cells, the azide-containing ligands can be autonomously transported intercellularly to adjacent cells and further spread throughout tumor tissues and label bioorthogonal ligands on cells that are not in proximity to blood vessels. Then, water-soluble dibenzocyclooctyne-modified chlorin e6 (DBCO-Ce6) was intravenously injected to react selectively, efficiently and irreversibly with the azide groups on the cell surface through an in vivo bioorthogonal click reaction. Enhanced tumor accumulation and penetration of DBCO-Ce6 was achieved through this strategy, resulting in improved therapeutic efficiency with laser irradiation for photodynamic therapy. Therefore, the artificial azide-containing ligand targeting strategy by nanoparticle-mediated metabolic labeling through the EPR effect combined with bioorthogonal click chemistry may provide an alternative strategy for enhanced tumor targeting and penetration with broad applications.

Dual-Responsive Metabolic Precursor and Light-Up AIEgen for Cancer Cell Bio-orthogonal Labeling and Precise Ablation.

Bioorthogonal Turn-On Probe Based on Aggregation-Induced Emission Characteristics for Cancer Cell Imaging and Ablation.

Near-Infrared Light Controlled Fluorogenic Labeling Of Glycoengineered Sialic Acids In Vivo With Upconverting Photoclick Nanoprobe

A Mitochondria-targeted AIEgen Labelled with <SUP>18</SUP>F for Breast Cancer Cell Imaging and Therapy

Redox-responsive Fluorescent AIE Bioconjugate with Aggregation Enhanced Retention Features for Targeted Imaging Reinforcement and Selective Suppression of Cancer Cells

Tumor Cell‐Specific Metabolic Labelling of Surface Sialoglycans and Post‐Click with Multivalent Rhamnose Enable Precise Immune Killing by Endogenous Antibody

A Light‐Up Probe with Aggregation‐Induced Emission for Real‐Time Bio‐orthogonal Tumor Labeling and Image‐Guided Photodynamic Therapy

In Vivo Targeting of Metabolically Labeled Cancers with Ultra-Small Silica Nanoconjugates

Building bioorthogonal click-release capable artificial receptors on cancer cell surface for imaging, drug targeting and delivery

Selective in vivo metabolic cell-labeling-mediated cancer targeting

Improved Tumor Targeting and Longer Retention Time of NIR Fluorescent Probes Using Bioorthogonal Chemistry.

Cancer Cell-Targeted Cisplatin Prodrug Delivery in Vivo Via Metabolic Labeling and Bioorthogonal Click Reaction

In Vivo Selective Imaging of Metabolic Glycosylation with a Tetrazine-Modified Upconversion Nanoprobe.

Targeted Imaging and Proteomic Analysis of Tumor‐Associated Glycans in Living Animals

In vivo cancer targeting via glycopolyester nanoparticle mediated metabolic cell labeling followed by click reaction.

Visualization of Protein-specific Glycosylation and Photodynamic Therapy <i>via</i> an Enzyme-free Amplification Strategy of Catalytic Hairpin Assembly and Hybridization Chain Reaction

Glycan Metabolic Fluorine Labeling for in Vivo Visualization of Tumor Cells and in Situ Assessment of Glycosylation Variations.

Intercellular delivery of bioorthogonal chemical receptors for enhanced tumor targeting and penetration

Bioorthogonal Light-Up Fluorescent Probe Enables Wash-Free Real-Time Dynamic Monitoring of Cellular Glucose Uptake

Cytosolic Protein Delivery Via Metabolic Glycoengineering And Bioorthogonal Click Reactions

Specific Light-Up Bioprobe With Aggregation-Induced Emission And Activatable Photoactivity For The Targeted And Image-Guided Photodynamic Ablation Of Cancer Cells